首页 | 本学科首页   官方微博 | 高级检索  
检索        

奥扎格雷联合低分子肝素治疗不稳定型心绞痛55例的临床研究
引用本文:郑健.奥扎格雷联合低分子肝素治疗不稳定型心绞痛55例的临床研究[J].中国现代医生,2011,49(9):50-51.
作者姓名:郑健
作者单位:浙江省苍南县中医院内科,浙江苍南,325800
摘    要:目的研究奥扎格雷联合低分子肝素治疗不稳定型冠心病心绞痛的疗效。方法将不稳定型冠心病心绞痛患者110例随机分组,对照组采取常规治疗,治疗组在常规治疗基础上加用奥扎格雷联合低分子肝素,服药14d后进行疗效评价。结果治疗组心电图总有效率为90.91%,而对照组为76.36%,两组比较有显著的统计学差异(P〈0.05);治疗组临床疗效总有效率94.55%,对照组为78.18%,两组比较有显著的统计学差异(P〈0.05)。结论治疗组不稳定型心绞痛的临床疗效及心电图疗效均优于对照组,奥扎格雷联合低分子肝素治疗不稳定型冠心病心绞痛疗效比较肯定。

关 键 词:奥扎格雷  低分子肝素  不稳定型心绞痛

Clinical Study of the Effect of Ozagrel Combined with LMWH on Patients with Unstable Angina Pectoris
Authors:ZHENG Jian
Institution:ZHENG Jian Department of Internal Medicine,Cangnan County TCM Hospital of Zhejiang Province,Cangnan 325800,China
Abstract:Objective To study the ozagrel combined with low molecular weight heparin(LMWH)'s clinical effect on patients with unstable angina pectoris.Methods 110 patients with unstable angina pectoris were divided randomly into control group and treatment group,the control group received regular therapeutic Methods,the treatment group received ozagrel and low molecular weight heparin additional.Evaluate the effect after two weeks' treatment.Results The treatment group's therapeutic effect is much better than the cont...
Keywords:Ozagrel  Low molecular weight heparin  Unstable angina pectoris  
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号